Expired European patentEurope
Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant
EP 1268759 B1 · Applicant: Genexine Co., Ltd.
Overview
The published document from the EPO: abstract, claims, description and drawings. Open it full size
Read the whole patent
Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 15, 2001 and granted September 27, 2006. A European patent lasts at most 20 years from filing, so its term ended March 15, 2021.
- A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by September 15, 2026.
- We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledMarch 15, 2001
PublishedJanuary 2, 2003
GrantedSeptember 27, 2006
Term endedMarch 15, 2021
Application numberEP 01914236
Classification (CPC)A61P35/00 +2 more
Timeline
Timeline From EPO dates
Sources & verification
Official EPO records
Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.